Involuntary Smoking and Head and Neck Cancer Risk: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

Although active tobacco smoking has been identified as a major risk factor for head and neck cancer, involuntary smoking has not been adequately evaluated because of the relatively low statistical power in previous studies. We took advantage of data pooled in the International Head and Neck Cancer Epidemiology Consortium to evaluate the role of involuntary smoking in head and neck carcinogenesis. Involuntary smoking exposure data were pooled across six case-control studies in Central Europe, Latin America, and the United States. Adjusted odds ratios (OR) and 95% confidence interval (95% CI) were estimated for 542 cases and 2,197 controls who reported never using tobacco, and the heterogeneity among the study-specific ORs was assessed. In addition, stratified analyses were done by subsite. No effect of ever involuntary smoking exposure either at home or at work was observed for head and neck cancer overall. However, long duration of involuntary smoking exposure at home and at work was associated with an increased risk (OR for >15 years at home, 1.60; 95% CI, 1.12-2.28; Ptrend < 0.01; OR for >15 years at work, 1.55; 95% CI, 1.04-2.30; Ptrend = 0.13). The effect of duration of involuntary smoking exposure at home was stronger for pharyngeal and laryngeal cancers than for other subsites. An association between involuntary smoking exposure and the risk of head and neck cancer, particularly pharyngeal and laryngeal cancers, was observed for long duration of exposure. These results are consistent with those for active smoking and suggest that elimination of involuntary smoking exposure might reduce head and neck cancer risk among never smokers. (Cancer Epidemiol Biomarkers Prev 2008;17(8):1974–81)

[1]  P. F. Kauff Group , 2000, Elegant Design.

[2]  T. Watts,et al.  Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium , 2007, BDJ.

[3]  S. Hecht A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder's opinion about ETS and lung cancer. , 2006, Preventive medicine.

[4]  M. Jaakkola,et al.  Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention , 2006, European Respiratory Journal.

[5]  P. Brennan,et al.  Evidence for an Important Role of Alcohol- and Aldehyde-Metabolizing Genes in Cancers of the Upper Aerodigestive Tract , 2006, Cancer Epidemiology Biomarkers & Prevention.

[6]  H. Morgenstern,et al.  Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus , 2006, International journal of cancer.

[7]  M. Spitz,et al.  Polymorphisms of Methionine Synthase and Methionine Synthase Reductase and Risk of Squamous Cell Carcinoma of the Head and Neck: a Case-Control Analysis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[8]  Stanton A Glantz,et al.  Cardiovascular health and economic effects of smoke-free workplaces. , 2004, The American journal of medicine.

[9]  J Smith,et al.  Tobacco and cancer: recent epidemiological evidence. , 2004, Journal of the National Cancer Institute.

[10]  R. Hayes,et al.  Tobacco and alcohol use and oral cancer in Puerto Rico , 1999, Cancer Causes & Control.

[11]  G. Pershagen,et al.  A European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls , 1998, Cancer Causes & Control.

[12]  E. Riboli,et al.  Exposure of nonsmoking women to environmental tobacco smoke: a 10-country collaborative study , 1990, Cancer Causes & Control.

[13]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[14]  T. Mccaffrey,et al.  The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. , 2002, Carcinogenesis.

[15]  H. Morgenstern,et al.  Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  W. Ahrens,et al.  Occupational exposure to carcinogens in the European Union , 2000, Occupational and environmental medicine.

[17]  J. Goedert,et al.  Salivary gland cancer in the United States. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[19]  E. Tan,et al.  Squamous cell head and neck cancer in nonsmokers. , 1997, American journal of clinical oncology.

[20]  K. Flegal,et al.  Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. , 1996, JAMA.

[21]  S Greenland,et al.  A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.

[22]  S. Hecht,et al.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. , 1988, Carcinogenesis.

[23]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[24]  S. Hecht,et al.  Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. , 1986, Cancer research.